What finance podcasts are saying aboutMirum Pharmaceuticals, Inc.MIRM
According to Zortix's podcast index, Mirum Pharmaceuticals, Inc. (MIRM) was discussed on 1 finance podcast across 1 episode in the 30 days to 12 Nov 2026, generating 1 attributed idea, most coverage from The Acquirers Podcast.
- 1
- 1
- 1
- 1
- 1
- Vs prior week
- +1
- Discussion depth
- Core-thesis conviction
As of 12 Nov 2026
Ask Zortix about MIRMDefinitions
- Mention
- One attributed idea naming this ticker, extracted from a podcast episode and dated by the episode’s air date. How we count →
- Attributed idea
- A specific argument a named speaker made on a named show, never an aggregate opinion, never Zortix’s view. What qualifies →
- Discussion depth
- How thoroughly an idea was argued on the episode, from a brief mention to a core thesis (a description of the conversation, not a rating of the stock). The bands →
- Stance mix
- Counts of attributed ideas by the side each argued on this name (bullish, balanced, or bearish as the speaker put it). A tally of the conversation’s sides, never a combined score, a rating, or Zortix’s view.